The positive regulatory impact of c-MYB on ESPL1/Separase expression explains well the observations of Patel and Gordon who found abnormally high Separase expression levels in CML cells of chronic and blast phase when compared to normal CD34+ cells. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.